Canton Strategic Holdings
Canton Strategic Holdings drives institutional blockchain adoption via the Canton Network, digital assets, and market digitization.
About Canton Strategic Holdings
Hillstream BioPharma is a development-stage company advancing improved therapies for patients with cancer via a unique QUATRAMERTM nanoparticle platform. This unique technology enables intranuclear and intracellular delivery of small molecules, peptides, genes, other macromolecules and biologics to the tumor cello, while significantly minimizing exposure to normal tissues.
Company Facts
- Headquarters
- Chester
- Founded
- 2017
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00011_00050
- Funding Stage
- ipo
- Total Funding
- $618,490,000
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2026-01-20
- Website
- https://tharimmune.com/
Industries & Categories
Biopharma, Biotechnology, Clinical Trials
Social Links
Canonical: https://fsome.com/organization/canton-strategic-holdings-32815 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.